Cargando…
Role of HMGB1 in Cisplatin-Persistent Lung Adenocarcinoma Cell Lines
Significant advances have been made recently in the development of targeted therapy for lung adenocarcinoma. However, platinum-based chemotherapy remains as the cornerstone in the treatment of this neoplasm. This is the treatment option for adenocarcinomas without EGFR gain-of-function mutations or...
Autores principales: | Chavez-Dominguez, Rodolfo L., Perez-Medina, Mario A., Lopez-Gonzalez, Jose S., Galicia-Velasco, Miriam, Matias-Florentino, Margarita, Avila-Rios, Santiago, Rumbo-Nava, Uriel, Salgado-Aguayo, Alfonso, Gonzalez-Gonzalez, Claudia, Aguilar-Cazares, Dolores |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710495/ https://www.ncbi.nlm.nih.gov/pubmed/34966671 http://dx.doi.org/10.3389/fonc.2021.750677 |
Ejemplares similares
-
Transcriptional signature of early cisplatin drug-tolerant persister cells in lung adenocarcinoma
por: Chavez-Dominguez, Rodolfo, et al.
Publicado: (2023) -
The Double-Edge Sword of Autophagy in Cancer: From Tumor Suppression to Pro-tumor Activity
por: Chavez-Dominguez, Rodolfo, et al.
Publicado: (2020) -
The systemic-level repercussions of cancer-associated inflammation mediators produced in the tumor microenvironment
por: Aguilar-Cazares, Dolores, et al.
Publicado: (2022) -
IL-6, NLR, and SII Markers and Their Relation with Alterations in CD8+ T-Lymphocyte Subpopulations in Patients Treated for Lung Adenocarcinoma
por: Islas-Vazquez, Lorenzo, et al.
Publicado: (2020) -
Partners in crime: The feedback loop between metabolic reprogramming and immune checkpoints in the tumor microenvironment
por: Benito-Lopez, Jesus J., et al.
Publicado: (2023)